BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 3089950)

  • 1. Serum levels and pharmacokinetics of ordinary and sustained-release lithium carbonate in manic patients during chronic dosage.
    Thornhill DP
    Int J Clin Pharmacol Ther Toxicol; 1986 May; 24(5):257-61. PubMed ID: 3089950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of ordinary and sustained-release lithium carbonate in manic patients after acute dosage.
    Thornhill DP
    Eur J Clin Pharmacol; 1978 Dec; 14(4):267-71. PubMed ID: 365541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel slow-release formulation of lithium carbonate (Carbolithium Once-A-Day) vs. standard Carbolithium: a comparative pharmacokinetic study.
    Castrogiovanni P
    Clin Ter; 2002; 153(2):107-15. PubMed ID: 12078335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absorption and disposition kinetics of lithium carbonate following administration of conventional and controlled release formulations.
    Arancibia A; Corvalan F; Mella F; Concha L
    Int J Clin Pharmacol Ther Toxicol; 1986 May; 24(5):240-5. PubMed ID: 3089949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correction of lithium levels for dose and blood sampling times.
    Swartz CM
    J Clin Psychiatry; 1987 Feb; 48(2):60-4. PubMed ID: 3804990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of standard (lithicarb) and sustained-release (Priadel) lithium carbonate preparations in patients.
    Johnson GF; Hunt GE; Lewis J; St George B
    Aust N Z J Psychiatry; 1982 Mar; 16(1):64-8. PubMed ID: 6810866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparative study of standard and slow-release oral lithium carbonate products.
    Wallis J; Miller R; McFadyen ML; Carlile JB
    S Afr Med J; 1989 Dec; 76(11):618-20. PubMed ID: 2512655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioavailability of lithium carbonate and lithium citrate: a comparison of two controlled-release preparations.
    Tyrer SP; Peat MA; Minty PS; Luchini A; Glud V; Amdisen A
    Pharmatherapeutica; 1982; 3(4):243-6. PubMed ID: 6815664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is the polarity of relapse/recurrence in bipolar-I disorder patients related to serum lithium levels? Results from an empirical study.
    Severus WE; Kleindienst N; Evoniuk G; Bowden C; Möller HJ; Bohus M; Frangou S; Greil W; Calabrese JR
    J Affect Disord; 2009 Jun; 115(3):466-70. PubMed ID: 19019453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Use of long-acting lithium carbonate--micalite--in the treatment of affective psychoses].
    Khvilivitskiĭ TIa; Mikhalenko IN; Zlatikina GN
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1977; 77(4):583-7. PubMed ID: 868433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single dose pharmacokinetics of a controlled release lithium preparation "Liskonum" in African patients suffering from manic depressive psychosis.
    Mengech HN; Ojwang PJ
    East Afr Med J; 1984 Apr; 61(4):321-5. PubMed ID: 6489236
    [No Abstract]   [Full Text] [Related]  

  • 12. Elevated serum bromide in patients taking lithium carbonate.
    Handorf CR; Coleman JH; Rawls WN
    J Clin Psychiatry; 1985 Jan; 46(1):9-10. PubMed ID: 3917430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A comparison of EEG changes with reaction time and serum lithium levels during treatment of manic patients with lithium carbonate].
    Shen JH
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1988 Apr; 21(2):83-6, 126-7. PubMed ID: 3145174
    [No Abstract]   [Full Text] [Related]  

  • 14. Three cases of severe mania successfully treated with high-dosage lithium-carbonate.
    Thau K; Meszaros K; Simhandl C
    Pharmacopsychiatry; 1991 May; 24(3):85-8. PubMed ID: 1909797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Slow-release lithium carbonate versus standard preparation in bipolar affective disorders (author's transl)].
    Bohacek N; Mihovilović M
    Lijec Vjesn; 1980 Oct; 102(10):575-9. PubMed ID: 6790888
    [No Abstract]   [Full Text] [Related]  

  • 16. [Use of individual pharmacokinetic parameters in establishing a regimen for lithium administration].
    Pop RD; Leucuţa SE; Domuţa M; Fodoreanu L; Barna D; Kovacs A; Gabor S
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Neurol Psihiatr Neurochir; 1984; 29(3):223-7. PubMed ID: 6239352
    [No Abstract]   [Full Text] [Related]  

  • 17. The effect of haloperidol on serum levels of lithium in adult manic patients.
    Schaffer CB; Batra K; Garvey MJ; Mungas DM; Schaffer LC
    Biol Psychiatry; 1984 Oct; 19(10):1495-9. PubMed ID: 6440599
    [No Abstract]   [Full Text] [Related]  

  • 18. Aspect of the pharmacokinetics of slow-release lithium carbonate.
    Hart GA
    S Afr Med J; 1984 Aug; 66(5):178-9. PubMed ID: 6431618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Compliance with and tolerance of sustained-release lithium carbonate].
    Lavantes B; Senimon F; Bayle FJ
    Encephale; 1999; 25(2):152-7. PubMed ID: 10370888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What is the optimal serum lithium level in the long-term treatment of bipolar disorder--a review?
    Severus WE; Kleindienst N; Seemüller F; Frangou S; Möller HJ; Greil W
    Bipolar Disord; 2008 Mar; 10(2):231-7. PubMed ID: 18271901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.